Ключевые слова:
Giyen–Barré sindromi; nafas yetishmovchiligi; intensiv terapiya; mexanik ventilyatsiya; avtonom disfunksiya; disautonomiya; mEGRIS; MRC sum score; bulbar falaj; neyrofilament light chain; biomarkerlar; respirator monitoring.Библиографические ссылки
1. Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nature Reviews Neurology. 2019;15:671–683.
2. Doorn PA, Van den Berg B, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome. European Journal of Neurology. 2023;30:3646–3674.
3. Walgaard C, Lingsma HF, Ruts L, et al. Prediction of respiratory insufficiency in Guillain–Barré syndrome. Annals of Neurology. 2010;67:781–789.
4. Ruts L, Drenthen J, Jacobs BC, et al. Distinguishing acute-onset CIDP from Guillain–Barré syndrome. Neurology. 2010;74:1680–1686.
5. Hafsteinsdóttir B, Farman H, Lagerström N, et al. Neurofilament light chain as a diagnostic and prognostic biomarker in Guillain–Barré syndrome. Journal of Neurology. 2024;271:7282–7293.
6. Dynamics and prognostic value of serum neurofilament light chain in Guillain–Barré syndrome. Journal of Neurology, Neurosurgery & Psychiatry. 2024.
7. Neurofilament light chain improves clinical prognostic models for Guillain–Barré syndrome. 2025.
8. van Koningsveld R, Steyerberg EW, Hughes RAC, Swan AV, van Doorn PA, Jacobs BC. A clinical prognostic scoring system for Guillain–Barré syndrome. Lancet Neurology. 2007;6:589–594.
9. Hughes RAC, Wijdicks EFM, Barohn R, et al. Practice parameter: immunotherapy for Guillain–Barré syndrome. Neurology. 2003;61:736–740.
10. Willison HJ, Jacobs BC, van Doorn PA. Guillain–Barré syndrome. Lancet. 2016;388:717–727.
11. Yuki N, Hartung HP. Guillain–Barré syndrome. New England Journal of Medicine. 2012; 366:2294–2304.
12. van den Berg B, Walgaard C, Drenthen J, et al. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews Neurology. 2014; 10:469–482.
13. Fokke C, van den Berg B, Drenthen J, et al. Diagnosis of Guillain–Barré syndrome and validation of Brighton criteria. Brain. 2014; 137:33–43.
14. Kuwabara S. Guillain–Barré syndrome. Current Neurology and Neuroscience Reports. 2007; 7:57–63.
15. Wakerley BR, Uncini A, Yuki N. Guillain–Barré and Miller Fisher syndromes—new diagnostic classification. Nature Reviews Neurology. 2014; 10:537–544.
16. Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain–Barré syndrome: a critical revision and the need for an update. Clinical Neurophysiology. 2012;123:1487–1495.
17. Ho TW, Willison HJ, Nachamkin I, et al. Anti-GD1a antibody is associated with axonal forms of Guillain–Barré syndrome. Annals of Neurology. 1999;45:168–173.
18. Jacobs BC, Rothbarth PH, van der Meché FGA, et al. The spectrum of antecedent infections in Guillain–Barré syndrome. Neurology. 1998; 51:11 10–1115.
19. Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain–Barré syndrome. Cochrane Database of Systematic Reviews. 2014.
20. Raphael JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain–Barré syndrome. Cochrane Database of Systematic Reviews.
21. Wijdicks EFM, Klein CJ. Guillain–Barré syndrome. Mayo Clinic Proceedings. 2017;92:467–479.
22. Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain–Barré syndrome. Journal of Clinical Neuromuscular Disease. 2018.
23. Newswanger DL, Warren CR. Guillain–Barré syndrome. American Family Physician. 2004; 69:2405–2410.
24. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Annals of Neurology. 1990;27–S24.
25. Jacobs BC, van Doorn PA, Schmitz PIM, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain–Barré syndrome. Annals of Neurology.
26. Neurofilaments as a severity and prognostic marker in Guillain–Barré syndrome. Neurology. 2024.
27. Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain–Barré syndrome. Neurology. 2023.
28. Predictors of respiratory failure in Guillain–Barré syndrome: a 22-year cohort study from a single Italian centre. European Journal of Neurology. 2024.
29. Neurofilament light chain levels as diagnostic and prognostic biomarkers in Guillain–Barré syndrome: an updated systematic review and meta-analysis. 2025.
30. Neurofilament light chain improves clinical prognostic models for Guillain–Barré syndrome. 2025.
